Novan's interim CEO outlines future focus
August 02, 2017 at 14:55 PM EDT
As of June 30, Novan had approximately $19 million in cash, according to interim CEO Kelly Martin – who is also CEO of Novan shareholder Malin Life Sciences Holding.
